National Pharmaceutical Services Association (NPSA)

Summary

On 27 March 2020, the National Pharmaceutical Services Association (NPSA) lodged an application for authorisation on behalf of itself, its members and CSO Distributors to coordinate to stabilise the supply chain for medicines and pharmacy products, which is currently disrupted as a result of the COVID-19 pandemic. The NPSA seeks authorisation to discuss, enter arrangements or engage in conduct for the purpose of facilitating the supply of, and access to, medicines and pharmacy products. The NPSA requested interim authorisation for this conduct on an urgent basis so that the NPSA and its members can start working together to address the ongoing pressure on supply chains.

On 31 March, the ACCC granted interim authorisation.

The ACCC invites submissions in relation to the application for authorisation by 23 April 2020. For further information about the application, and how to provide a submission to the ACCC, please refer to the links below.

An indicative timetable is set out below for your information

Indicative date

Stage in assessment process

27 March 2020

Lodgement of application

31 March 2020

ACCC decision on interim authorisation

2 April 2020

Consultation on the application and interim authorisation commences

23 April 2020

Closing date for submissions

14 May 2020

Applicants respond to issues raised in public consultation process

June/July 2020

ACCC draft determination

July/August 2020

Public consultation on the draft determination including any conference if called

September 2020

Final determination

Applicant(s)

  • National Pharmaceutical Services Association

Authorisation number(s)

  • AA1000480-1

Applications

Document title Date

Decisions

Document title Date

Submissions - before draft decision